Search
Teglarinad chloride
go.drugbank.com/drugs/DB05217InvestigationalGMX1777 is a water-soluble prodrug of the cyanoguanidine compound GMX1778 with potential antineoplastic activity. In vivo, apoptosis inducer GMX1777 is rapidly converted into GMX1778 through hydrolytic cleavage of a carbonate ester bond....
Razuprotafib
go.drugbank.com/drugs/DB16353InvestigationalRazuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting VE-PTP. In investigations against diabetes and COVID-19, razuprotafib is self-administered by patients through subcutaneous injec...
Recombinant human plasma gelsolin
go.drugbank.com/drugs/DB15746InvestigationalPlasma gelsolin (pGSN) is a protein found in the blood of healthy individuals which scavenges compounds left over from damaged tissues.
Troxerutin
go.drugbank.com/drugs/DB13124InvestigationalTroxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
Mixtures: GINKOR FORT CAPSULEFucoxanthin
go.drugbank.com/drugs/DB15462InvestigationalFucoxanthin is investigated for its anti-inflammatory, antinociceptive and anti-cancer effects. … Fucoxanthin isis a marine carotenoid mainly found in brown algae, giving them a brown or olive-green color.
Chlorothiazide
go.drugbank.com/drugs/DB00880ApprovedInvestigationalVet approvedA thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
D-arginine
go.drugbank.com/drugs/DB04027ExperimentalA D-α-amino acid that is the D-isomer of arginine (only the L-form is physiologically active).
Methysergide
go.drugbank.com/drugs/DB00247ApprovedWithdrawnAn ergot derivative that is a congener of lysergic acid diethylamide. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is us...
Categories: Heterocyclic Compounds with 4 or More RingsOctacosanol
go.drugbank.com/drugs/DB11220InvestigationalNutraceuticalIt has been studied as a potential therapeutic agent for the treatment of Parkinson's disease.